tacrine has been researched along with cysteine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallikainen, M; Helkala, EL; Kuikka, J; Riekkinen, P; Soininen, H | 1 |
| Helkala, EL; Kuikka, J; Laakso, M; Partanen, J; Riekkinen, M; Riekkinen, P; Soininen, H | 1 |
| Cusack, B; Fauq, A; Hughes, TF; Johnson, JL; McCullough, EH; Romanovskis, P; Rosenberry, TL; Spatola, AF | 1 |
| Boyd, AE; Dunlop, CS; Johnson, DA; Radic, Z; Taylor, P; Wong, L | 1 |
| Akaike, A; Fujii, T; Katsuki, H; Kume, T; Niidome, T; Okabe, S; Sugimoto, H; Sugimoto, M; Takada-Takatori, Y | 1 |
| Jing, L; Liang, C; Shi, X; Tian, Y; Xian, Y; Ye, S | 1 |
| Chaves, S; Keri, RS; Quintanova, C; Santos, MA | 1 |
| Cardoso, SM; Chaves, S; Keri, RS; Quintanova, C; Santos, MA; Silva, DF | 1 |
2 trial(s) available for tacrine and cysteine
| Article | Year |
|---|---|
Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging.
Topics: Aged; Alzheimer Disease; Brain; Cerebellum; Cholinesterase Inhibitors; Cysteine; Double-Blind Method; Female; Humans; Male; Nootropic Agents; Organotechnetium Compounds; Tacrine; Tomography, Emission-Computed, Single-Photon | 1995 |
Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amygdala; Apolipoprotein E4; Apolipoproteins E; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cysteine; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Parasympathetic Nervous System; Plaque, Amyloid; Tacrine; Tomography, Emission-Computed, Single-Photon | 1998 |
6 other study(ies) available for tacrine and cysteine
| Article | Year |
|---|---|
Inhibitors tethered near the acetylcholinesterase active site serve as molecular rulers of the peripheral and acylation sites.
Topics: Acetylcholinesterase; Binding Sites; Cations; Cysteine; Disulfides; Dose-Response Relationship, Drug; Humans; Hydrolysis; Kinetics; Ligands; Models, Chemical; Models, Molecular; Models, Statistical; Mutagenesis, Site-Directed; Mutation; Propidium; Protein Binding; Recombinant Proteins; Tacrine | 2003 |
Nanosecond dynamics of acetylcholinesterase near the active center gorge.
Topics: Acetylcholinesterase; Anisotropy; Binding Sites; Catalysis; Cell Line; Cysteine; DNA Mutational Analysis; Elapid Venoms; Humans; Kinetics; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Conformation; Tacrine; Time Factors | 2004 |
Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Cysteine; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Fetus; Galantamine; Glutamic Acid; Ionomycin; Ionophores; Mecamylamine; Neuroprotective Agents; Nicotinic Antagonists; Nitric Oxide Donors; Rats; Rats, Wistar; S-Nitrosothiols; Tacrine | 2006 |
An electrochemical platform for acetylcholinesterase activity assay and inhibitors screening based on Michael addition reaction between thiocholine and catechol-terminated SAMs.
Topics: Acetylcholinesterase; Acetylthiocholine; Biosensing Techniques; Carbofuran; Catechols; Cholinesterase Inhibitors; Cysteine; Electrochemical Techniques; Electrodes; Glutathione; Gold; Methyl Parathion; Tacrine; Thiocholine | 2011 |
Copper(II) complexation of tacrine hybrids with potential anti-neurodegenerative roles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chelating Agents; Cholinesterase Inhibitors; Coordination Complexes; Copper; Cysteine; Humans; Hydrogen-Ion Concentration; Models, Molecular; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Tacrine | 2015 |
New Tacrine Hybrids with Natural-Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Cysteine; Humans; Tacrine | 2016 |